Status: Currently enrolling
ClinicalTrials.gov Identifier: NCT03126786
CLS1004-201: A Phase II, randomized, masked, controlled trial to study the Safety and Efficacy of Suprachoroidal CLS-TA in conjunction with Intravitreal Aflibercept in patients with Diabetic Macular Edema.
Condition: Diabetic Macular Edema
Study Type: Interventional
Duration: 24 weeks
Eligibility:
For additional information on this study, please click here
Back to Clinical Research